Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epileptic syndromes: From clinic to genetic.
Tafakhori A, Aghamollaii V, Faghihi-Kashani S, Sarraf P, Habibi L. Tafakhori A, et al. Iran J Neurol. 2015 Jan 5;14(1):1-7. Iran J Neurol. 2015. PMID: 25874049 Free PMC article. Review.
Nutritional Aspects of Treatment in Epileptic Patients.
Soltani D, Ghaffar Pour M, Tafakhori A, Sarraf P, Bitarafan S. Soltani D, et al. Among authors: tafakhori a. Iran J Child Neurol. 2016 Summer;10(3):1-12. Iran J Child Neurol. 2016. PMID: 27375750 Free PMC article. Review.
The Combined Effects of ω -3 Fatty Acids and Nano-Curcumin Supplementation on Intercellular Adhesion Molecule-1 (ICAM-1) Gene Expression and Serum Levels in Migraine Patients.
Soveyd N, Abdolahi M, Djalali M, Hatami M, Tafakhori A, Sarraf P, Honarvar NM. Soveyd N, et al. Among authors: tafakhori a. CNS Neurol Disord Drug Targets. 2018 Mar 13;16(10):1120-1126. doi: 10.2174/1871527317666171213154749. CNS Neurol Disord Drug Targets. 2018. PMID: 29237386 Clinical Trial.
Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial.
Ahmadi M, Agah E, Nafissi S, Jaafari MR, Harirchian MH, Sarraf P, Faghihi-Kashani S, Hosseini SJ, Ghoreishi A, Aghamollaii V, Hosseini M, Tafakhori A. Ahmadi M, et al. Among authors: tafakhori a. Neurotherapeutics. 2018 Apr;15(2):430-438. doi: 10.1007/s13311-018-0606-7. Neurotherapeutics. 2018. PMID: 29352425 Free PMC article. Clinical Trial.
Molecular mechanisms of omega-3 fatty acids in the migraine headache.
Soveyd N, Abdolahi M, Bitarafan S, Tafakhori A, Sarraf P, Togha M, Okhovat AA, Hatami M, Sedighiyan M, Djalali M, Mohammadzadeh Honarvar N. Soveyd N, et al. Among authors: tafakhori a. Iran J Neurol. 2017 Oct 7;16(4):210-217. Iran J Neurol. 2017. PMID: 29736227 Free PMC article. Review.
A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study.
Abdolahi M, Sarraf P, Javanbakht MH, Honarvar NM, Hatami M, Soveyd N, Tafakhori A, Sedighiyan M, Djalali M, Jafarieh A, Masoudian Y, Djalali M. Abdolahi M, et al. Among authors: tafakhori a. CNS Neurol Disord Drug Targets. 2018;17(6):430-438. doi: 10.2174/1871527317666180625101643. CNS Neurol Disord Drug Targets. 2018. PMID: 29938621 Clinical Trial.
154 results